These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 19778527

  • 1. Use of interval-specific likelihood ratios improves clinical interpretation of serum FLC results for the diagnosis of malignant plasma cell disorders.
    Vermeersch P, Vercammen M, Holvoet A, Vande Broek I, Delforge M, Bossuyt X.
    Clin Chim Acta; 2009 Dec; 410(1-2):54-8. PubMed ID: 19778527
    [Abstract] [Full Text] [Related]

  • 2. Clinical usefulness of free light chain concentration as a tumor marker in multiple myeloma.
    Kang SY, Suh JT, Lee HJ, Yoon HJ, Lee WI.
    Ann Hematol; 2005 Sep; 84(9):588-93. PubMed ID: 15883850
    [Abstract] [Full Text] [Related]

  • 3. International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders.
    Dispenzieri A, Kyle R, Merlini G, Miguel JS, Ludwig H, Hajek R, Palumbo A, Jagannath S, Blade J, Lonial S, Dimopoulos M, Comenzo R, Einsele H, Barlogie B, Anderson K, Gertz M, Harousseau JL, Attal M, Tosi P, Sonneveld P, Boccadoro M, Morgan G, Richardson P, Sezer O, Mateos MV, Cavo M, Joshua D, Turesson I, Chen W, Shimizu K, Powles R, Rajkumar SV, Durie BG, International Myeloma Working Group.
    Leukemia; 2009 Feb; 23(2):215-24. PubMed ID: 19020545
    [Abstract] [Full Text] [Related]

  • 4. Serum free light chain measurement aids the diagnosis of myeloma in patients with severe renal failure.
    Hutchison CA, Plant T, Drayson M, Cockwell P, Kountouri M, Basnayake K, Harding S, Bradwell AR, Mead G.
    BMC Nephrol; 2008 Sep 22; 9():11. PubMed ID: 18808676
    [Abstract] [Full Text] [Related]

  • 5. Diagnostic performance of serum free light chain measurement in patients suspected of a monoclonal B-cell disorder.
    Vermeersch P, Van Hoovels L, Delforge M, Mariën G, Bossuyt X.
    Br J Haematol; 2008 Nov 22; 143(4):496-502. PubMed ID: 18729849
    [Abstract] [Full Text] [Related]

  • 6. Assessing the efficiency of free light chain assay in monitoring patients with multiple myeloma before and after autologous stem cell transplantation along with serum protein electrophoresis and serum protein immunofixation.
    Dogaru M, Lazăr V, Coriu D.
    Roum Arch Microbiol Immunol; 2011 Nov 22; 70(1):15-22. PubMed ID: 21717807
    [Abstract] [Full Text] [Related]

  • 7. [Clinical significance of measurement of free light chains].
    Matsuda M.
    Rinsho Byori; 2010 Apr 22; 58(4):401-4. PubMed ID: 20496770
    [Abstract] [Full Text] [Related]

  • 8. Quantitative serum free light chain assay in the diagnostic evaluation of AL amyloidosis.
    Akar H, Seldin DC, Magnani B, O'Hara C, Berk JL, Schoonmaker C, Cabral H, Dember LM, Sanchorawala V, Connors LH, Falk RH, Skinner M.
    Amyloid; 2005 Dec 22; 12(4):210-5. PubMed ID: 16399645
    [Abstract] [Full Text] [Related]

  • 9. Development of a highly-sensitive multi-plex assay using monoclonal antibodies for the simultaneous measurement of kappa and lambda immunoglobulin free light chains in serum and urine.
    Campbell JP, Cobbold M, Wang Y, Goodall M, Bonney SL, Chamba A, Birtwistle J, Plant T, Afzal Z, Jefferis R, Drayson MT.
    J Immunol Methods; 2013 May 31; 391(1-2):1-13. PubMed ID: 23388695
    [Abstract] [Full Text] [Related]

  • 10. Assessment of the analytical performance and the sensitivity of serum free light chains immunoassay in patients with monoclonal gammopathy.
    Wolff F, Thiry C, Willems D.
    Clin Biochem; 2007 Mar 31; 40(5-6):351-4. PubMed ID: 17239359
    [Abstract] [Full Text] [Related]

  • 11. [Evaluation of the clinical relevance of serum measurements of free-light chains in patients with multiple myeloma].
    Shimizu K, Itoh J, Sugiura I, Tsushita K, Kosugi H, Nagura E.
    Rinsho Ketsueki; 2006 Apr 31; 47(4):303-9. PubMed ID: 16715965
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Serum immunoglobulin free light chain assessment in rheumatoid arthritis and primary Sjogren's syndrome.
    Gottenberg JE, Aucouturier F, Goetz J, Sordet C, Jahn I, Busson M, Cayuela JM, Sibilia J, Mariette X.
    Ann Rheum Dis; 2007 Jan 31; 66(1):23-7. PubMed ID: 16569685
    [Abstract] [Full Text] [Related]

  • 16. Polyclonal free light chain of Ig may interfere with interpretation of monoclonal free light chain κ/λ ratio.
    Levinson SS.
    Ann Clin Lab Sci; 2010 Jan 31; 40(4):348-53. PubMed ID: 20947809
    [Abstract] [Full Text] [Related]

  • 17. Serum free light chains for monitoring multiple myeloma.
    Mead GP, Carr-Smith HD, Drayson MT, Morgan GJ, Child JA, Bradwell AR.
    Br J Haematol; 2004 Aug 31; 126(3):348-54. PubMed ID: 15257706
    [Abstract] [Full Text] [Related]

  • 18. Presence of monoclonal free light chains in the serum predicts risk of progression in monoclonal gammopathy of undetermined significance.
    Rajkumar SV, Kyle RA, Therneau TM, Clark RJ, Bradwell AR, Melton LJ, Larson DR, Plevak MF, Katzmann JA.
    Br J Haematol; 2004 Nov 31; 127(3):308-10. PubMed ID: 15491291
    [Abstract] [Full Text] [Related]

  • 19. Analytical performance of serum free light-chain assay during monitoring of patients with monoclonal light-chain diseases.
    Tate JR, Mollee P, Dimeski G, Carter AC, Gill D.
    Clin Chim Acta; 2007 Feb 31; 376(1-2):30-6. PubMed ID: 16945362
    [Abstract] [Full Text] [Related]

  • 20. Diagnostic approach to and follow-up of difficult cases of AL amyloidosis.
    Perfetti V, Garini P, Vignarelli MC, Marinone MG, Zorzoli I, Merlini G.
    Haematologica; 1995 Feb 31; 80(5):409-15. PubMed ID: 8566880
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.